Vol 13, No 4 (April 30, 2024): Translational Andrology and Urology

Real-world clinical effectiveness of nonsurgical treatments for female with POP-Q stage II cystocele: a retrospective analysis of therapeutic efficacy

Survival nomogram and risk classification system for patients with adrenocortical carcinoma: a study based on the SEER database and external validation in China

Identification of a lactate metabolism-related lncRNAs signature for predicting the prognosis in patients with kidney renal clear cell carcinoma

Porous Se@SiO₂ nanocomposites play a potential inhibition role in hyperoxaluria associated kidney stone by exerting antioxidant effects

Nitro-oleic acid (NO₂-OA) ameliorates erectile dysfunction in a rat model of diabetes mellitus via modulation of fibrosis, inflammation and autophagy

Differential effects of obesity on perioperative outcomes in renal cell carcinoma patients based on race and ethnicity and neighborhood-level socioeconomic status

Microscopic subinguinal varicocelectomy with video telescopic operating microscope (VITOM) telescope: outcome analysis

Complicated artificial urinary sphincter insertion using the transcorporal cuff: keys to the tunical flap technique

Penile prosthesis in priapism: a systematic review of outcomes and complications

Narrative review of immediate salvage for penile prosthesis infection

A contemporary systematic review of penile lengthening procedures with penile prosthesis

Overcoming barriers to immediate penile implant salvage surgery: a narrative review

European association of urology biochemical recurrence risk stratification in the context of post-prostatectomy salvage therapy

Metabolic enzymes moonlighting to drive enzalutamide resistance in prostate cancer

Effectiveness of switch therapy from tyrosine kinase inhibitors to immune checkpoint inhibitors: the need for biomarkers to establish treatment strategies in patients with metastatic renal cell carcinoma

Refining the subgroup analyses and optimal patient population in the JAVELIN Bladder 100 trial

Chemoablation with UGN-102 in intermediate-risk non-muscle invasive bladder cancer, are we there yet?

Management of small renal mass: unmet needs and quest for high quality evidence

Ablative therapy with UGN-102 for low-grade intermediate risk non-muscle-invasive bladder cancer: ready for primetime?

What is the key factor determining effectiveness of radiotherapy for high-risk prostate cancer: a hidden message from RTOG 0521

A critical evaluation of Optilume^® BPH as a novel minimally invasive surgical treatment for the management of lower urinary tract symptoms in men